structure of 5-METHOXY-6-METHYL-7-AZAINDOLE

5-METHOXY-6-METHYL-7-AZAINDOLE

CAS No.: 1000340-90-8
M. Wt: 162.189
M. Fa: C9H10N2O
InChI Key: -

Names and Identifiers of 5-METHOXY-6-METHYL-7-AZAINDOLE

CAS Number

1000340-90-8

IUPAC Name

5-methoxy-6-methyl-1H-pyrrolo[2,3-b]pyridine

Canonical SMILES

CC1=C(C=C2C=CNC2=N1)OC

Physical and chemical properties of 5-METHOXY-6-METHYL-7-AZAINDOLE

Density

1.2±0.1 g/cm3

Exact Mass

162.079315

Index of Refraction

1.629

LogP

2.63

Molecular Formula

C9H10N2O

Molecular Weight

162.189

PSA

37.91000

Applications of 5-METHOXY-6-METHYL-7-AZAINDOLE

5-Methoxy-6-methyl-1H-pyrrolo[2,3-b]pyridine has potential applications in various fields:

  • Pharmaceutical Development: As an FGFR inhibitor, it is being explored for its therapeutic potential in treating cancers associated with aberrant FGFR signaling.
  • Chemical Biology: The compound serves as a tool for studying FGFR-related pathways and mechanisms.
  • Material Science: Its unique structure may find applications in the development of novel materials with specific electronic or optical properties.

Interaction Studies of 5-METHOXY-6-METHYL-7-AZAINDOLE

Studies have shown that 5-methoxy-6-methyl-1H-pyrrolo[2,3-b]pyridine interacts effectively with FGFRs through hydrogen bonding and hydrophobic interactions. Specifically, the methoxy group can occupy hydrophobic pockets within the receptor's active site, enhancing binding affinity and specificity. This interaction profile is crucial for its biological efficacy and therapeutic potential.

Biological Activity of 5-METHOXY-6-METHYL-7-AZAINDOLE

Research indicates that 5-methoxy-6-methyl-1H-pyrrolo[2,3-b]pyridine exhibits significant biological activity, particularly as an inhibitor of Fibroblast Growth Factor Receptors (FGFRs). These receptors play crucial roles in cell proliferation, differentiation, and survival. Inhibition of FGFRs by this compound can lead to decreased cell proliferation and increased apoptosis in cancer cells, making it a candidate for anticancer therapies.